Bradykinesia News and Research

RSS

New blood test pinpoints Parkinson's disease through mitochondrial DNA damage

Researchers have developed a new blood test that measures mitochondrial DNA damage as a potential marker for Parkinson's disease (PD). The study shows the test could aid in diagnosing PD and assessing responses to LRRK2 kinase inhibitors, which may help in reducing mitochondrial damage in PD patients.

4 Sep 2023

Could AI be the game-changer in remote Parkinson's diagnosis?

New AI tool for Parkinson's diagnosis outperforms certified raters and nearly matches experts, using webcam-captured videos of finger-tapping tests. The technology holds promise for remote, automatic diagnosis, especially in regions lacking neurological care.

28 Aug 2023

Beyond diagnosis: coping strategies and their influence on Parkinson's patients' well-being

Researchers determined the predictors of particular coping methods used by Parkinson's Disease (PD).

30 Jun 2023

Early hallucinations may indicate faster cognitive decline in patients with Parkinson's disease

Have you ever felt the strong sensation that someone is behind you, so intense that you turn around, only to see that no-one is there? This is a 'presence hallucination'.

29 Jun 2023

A machine-learning approach for the early diagnosis of Parkinson's disease

Scientists discuss a machine learning-based tool that can detect Parkinson's disease years before the first onset of symptoms.

11 May 2023

Is exposure to metal associated with the risk of Parkinson's disease?

Researchers reviewed the literature on metal exposure and Parkinson's disease risk.

7 Apr 2023

Exploring the neuroprotective potential of cell-penetrating peptides, extracellular vesicles, and micro ribonucleic acids

In a recent review published in Biomedicines, researchers explored extracellular vesicles (EVs), cell-penetrating peptides (CPPs), and micro ribonucleic acids (miRNAs) as therapies for neurodegenerative diseases such as Alzheimer’s disease (AD) and Parkinson’s disease (PD).

1 Mar 2023

Long COVID, a new clinical entity constantly evolving

Researchers discuss the epidemiology, diagnosis, pathogenesis, and treatment of long COVID.

27 Oct 2022

Smartphone App could help advance the early detection of Parkinson's disease and severe COVID-19

A new screening test App could help advance the early detection of Parkinson's disease and severe COVID-19, improving the management of these illnesses.

5 Oct 2022

The currently available evidence on viral-induced parkinsonism

A new review attempts to summarize all known about the relationship between viral illness and parkinsonian disorders to facilitate further research.

31 Aug 2022

Exploring the connection between Parkinson's disease and gut microbiota to uncover potential therapeutic targets

Scientists have published a new review focusing on the relationship between PD and gut microbiota.

15 Jul 2022

New biomarker may enable rapid, inexpensive diagnosis of Parkinson's disease

Researchers at Kobe University and Hiroshima University have successfully developed a biomarker that will enable Parkinson's disease to be rapidly and inexpensively diagnosed from blood serum samples.

26 May 2022

Cannabidiol for Parkinson's disease symptom management

Scientists have published a review study in the Journal for Nurse Practitioners that has focussed on various aspects of the use of cannabidiol in Parkinson's.

17 May 2022

Older people taking statins have lower chance of developing parkinsonism later, study suggests

Parkinsonism is a term for a group of neurological conditions that cause movement problems including tremors, slowed movement and stiffness, with Parkinson's disease being one of the better knowns causes.

24 Mar 2022

Aerobic exercise combined with tDCS improves the gait of Parkinson's patients

Transcranial direct current stimulation (tDCS) can increase the benefits of aerobic exercise and improve the gait of patients with Parkinson's disease immediately after a session. Step time variability decreases, reaction time shortens, and executive control of gait is enhanced.

25 Aug 2021

A look at how coronavirus disease (COVID-19) affects Parkinson's

Earlier, herpes simplex virus (HSV), influenza virus A, measles virus, cytomegalovirus (CMV), and mumps virus have all been associated with after-effects of the virus that includes Parkinson's disease (PD). This list may now include SARS-CoV-2.

14 May 2021

Pioneering neural recordings lay the groundwork for personalized Parkinson's treatments

Pioneering neural recordings in patients with Parkinson's disease by UC San Francisco scientists lays the groundwork for personalized brain stimulation to treat Parkinson's and other neurological disorders.

4 May 2021

Researchers survey patients to find out which Parkinson's symptoms troubled the most

Individuals with Parkinson's disease (PD) face a wide range of symptoms and challenges. A team from Parkinson's UK, including several Patient and Public Involvement (PPI) contributors, surveyed patients to find out which PD symptoms troubled them most and how priorities may change with condition duration.

27 Apr 2021

Anti-diabetic drug could be repurposed for treating Parkinson's disease

A hallmark of Parkinson's disease is the degeneration of a group of dopaminergic neurons in the brain, which play key roles in movement initiation and co-ordination.

24 Nov 2020

Parkinson's disease breakthrough seen in mouse model

Researchers from the University of California San Diego School of Medicine have found a way to create new neurons in a mouse model of Parkinson's disease. The severely debilitating and progressive neurodegenerative disease, as of now, has no cure, and this breakthrough could help hundreds of thousands of patients with the condition feel experts.

25 Jun 2020